IL6 and obesity disorder: In the context of obesity and insulin resistance, its clinical utility lies in detecting low-grade metabolic inflammation arising from excess adipose tissue—particularly visceral adiposity—through sustained cytokine release (e.g., IL-6) that stimulates hepatic CRP synthesis [1,2,3].